Needle-free Injection System - Stratis(R) - was used to deliver Scancell's iSCIB1+ DNA immunotherapy in combination with immune checkpoint inhibitors in the SCOPE Phase 2 trial. -- The Scancell ...
PharmaJet will deliver two presentations on October 27 focusing on current and future applications of their needle-free technology. The Tropis® intradermal (ID) Needle-free Injection System overcomes ...
97% of healthcare workers preferred Tropis® ID for routine immunization. Vaccinators noted Tropis is easy to operate, resulted in less perceived child discomfort, and elicits a positive caregiver ...
PharmaJet presentation will highlight the results of recent immunization studies using needle-free intradermal (ID) delivery for polio immunization campaigns. Data reinforces how increased coverage, ...
The Global Intradermal Injection Industry is poised for unprecedented growth, with an anticipated valuation of over US$ 3,878 Million in 2022, soaring to new heights with a projected compound annual ...
Injections are an essential part of medical treatment and play a crucial role in administering medications, vaccinations, and other therapeutics. There are several methods to give an injection, each ...
A Rutgers Health survey of LGBTQ+ individuals in New York and New Jersey reveals that cisgender men, gay individuals and full-time employees had the highest rates of vaccination for Mpox, a viral ...
First human DNA vaccine First in class thermostable self-amplifying mRNA vaccine GOLDEN, Colo.--(BUSINESS WIRE)--PharmaJet ®, a company engineering precision delivery systems that overcome challenges ...
The Global Intradermal Injection Market is expected to surpass an impressive valuation of US$ 3,878 Million in 2022, with a compound annual growth rate (CAGR) of 10.8% from 2022 to 2032. In recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback